STI and Implications for HIV Transmission and Prevention

性传播感染以及对艾滋病毒传播和预防的影响

基本信息

  • 批准号:
    9334534
  • 负责人:
  • 金额:
    $ 46.6万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-04-01 至 2021-03-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY Despite making up only 2% of the US population, men who have sex with men (MSM) accounted for 67% of new HIV infections in 2014, and incidence rates among adolescent MSM are alarmingly high in some areas. One potential barrier to the effectiveness of biomedical HIV prevention interventions among MSM is the physiologic efficiency of HIV transmission across the rectal mucosa, where approximately 70% of infections are thought to occur among MSM. However, the majority of HIV mucosal transmission research has concentrated on vaginal transmission in women and non-human primates, which is then extrapolated to understanding the mechanisms of rectal transmission among MSM. In addition, the role of inflammation in the rectal mucosa attributed to bacterial sexually transmitted infections (STI), including Chlamydia (CT), Gonorrhea (GC), and syphilis, has been understudied to date despite the tremendous burden of STI in MSM and their influence on HIV transmission. We have previously shown that rectal STI, even in the setting of routine screening and treatment, is associated with HIV seroconversion in a cohort of HIV-negative MSM. For HIV positive MSM, our prior work shows that rectal shedding of HIV remains low in men on suppressive antiretroviral therapy (ART) with rectal GC and/or CT; however, sampling of the mucosa was not optimal to detect low level shedding in this study. In the absence of rectal STI, preliminary data presented in this application with adult HIV-negative MSM aged 18-45 show a distinct innate and adaptive pro-inflammatory immune response to condomless receptive anal intercourse (CRAI) in the rectal mucosa, and that the diversity and composition of the rectal mucosal microbiota differ between adult MSM who engage in CRAI versus men who do not engage in anal intercourse (AI) with MSM engaging in CRAI being enriched for the family Prevotellaceae. In this application, we propose to expand our rectal mucosal studies of MSM to examine the effect of bacterial STI on the rectal mucosal resident cellular populations (aim1) and the microbiome (aim2). In aim 3, we will study resolution of inflammation after treatment of STI and its effect on ex vivo HIV infection of the rectal mucosa. We will build upon our successful translational mucosal immunology program with a highly successful clinical research and retention infrastructure that was designed to understand factors that may influence rectal transmission among MSM. A better understanding of the host response to STI in the rectum will be useful to the design of biomedical HIV and bacterial STI prevention mechanisms, including effective vaccines.
项目总结 尽管只占美国人口的2%,但男男性行为者(MSM)占到了67% 2014年新增艾滋病毒感染,一些地区青少年男男性接触者的发病率高得令人震惊。 在男男性行为者中进行生物医学艾滋病毒预防干预的一个潜在障碍是 艾滋病毒通过直肠粘膜传播的生理效率,大约70%的感染是通过直肠粘膜传播的 被认为发生在男男性接触者中。然而,大多数关于艾滋病毒粘膜传播的研究已经 集中在女性和非人类灵长类动物的阴道传播上,然后推断为 了解男男性接触者的直肠传播机制。此外,炎症在血管紧张性疾病中的作用 直肠粘膜可归因于细菌性传播感染(STI),包括衣原体(CT)、淋病 (GC)和梅毒,尽管MSM和他们的STI造成了巨大的负担,但迄今为止对梅毒的研究还不够充分 对艾滋病毒传播的影响。我们以前已经证明,直肠STI,即使在常规的设置下 筛查和治疗与HIV阴性男男性接触者队列中的HIV血清转换有关。针对HIV病毒 阳性的男男性接触者,我们先前的工作表明,在抑制的男性中,艾滋病毒的直肠排出保持在低水平 使用直肠GC和/或CT进行抗逆转录病毒治疗(ART);然而,粘膜采样并不是治疗 在这项研究中检测到低水平的脱落。在没有直肠STI的情况下,本研究提供的初步数据 18-45岁成年HIV阴性MSM的应用显示出明显的先天和适应性促炎作用 直肠黏膜对无套式接受性肛交的免疫反应及其多样性 从事CRAI的成年男男性接触者的直肠粘膜微生物区系组成与男性不同 那些不与男男性接触者进行肛交(AI)的人为家庭增加了CRAI 雷公藤科。在这项应用中,我们建议扩大我们对MSM的直肠粘膜研究,以检查 细菌STI对直肠粘膜驻留细胞群(AIM1)和微生物群(AIM2)的影响。在……里面 目的3、研究STI治疗后炎症的消退及其对体外HIV感染的影响。 直肠粘膜。我们将在我们成功的翻译黏膜免疫学计划的基础上,通过高度的 成功的临床研究和保留基础设施,旨在了解可能 对男男性接触者直肠传播的影响。更好地了解宿主对直肠STI的反应 将有助于设计生物医学艾滋病毒和细菌性传播感染预防机制,包括有效的 疫苗。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Colleen F Kelley其他文献

Safety, pharmacokinetics, and neutralisation activity of PGDM1400LS, a V2 specific HIV-1 broadly neutralising antibody, infused intravenously or subcutaneously in people without HIV-1 in the USA (HVTN 140/HPTN 101 part A): a first-in-human, phase 1 randomised trial
PGDM1400LS 是一种 V2 特异性 HIV-1 广泛中和抗体,在美国无 HIV-1 人群中静脉或皮下输注的安全性、药代动力学和中和活性(HVTN 140/HPTN 101 A 部分):一项首次人体、1 期随机试验
  • DOI:
    10.1016/s2352-3018(25)00012-8
  • 发表时间:
    2025-06-01
  • 期刊:
  • 影响因子:
    13.000
  • 作者:
    Kelly E Seaton;Carmen A Paez;Chenchen Yu;Shelly T Karuna;Theresa Gamble;Maurine D Miner;Jack Heptinstall;Lu Zhang;Fei Gao;Margaret Yacovone;Hans Spiegel;Julie B Dumond;Maija Anderson;Estelle Piwowar-Manning;Bonnie Dye;India Tindale;Lori Proulx-Burns;Meg Trahey;Simbarashe Takuva;Azwidihwi Takalani;Colleen F Kelley
  • 通讯作者:
    Colleen F Kelley
Phase 1 Open-Label Dose Escalation Trial for the Development of a Human Bacillus Calmette-Guérin Challenge Model for Assessment of Tuberculosis Immunity In Vivo.
开发用于评估体内结核病免疫力的人类卡介苗挑战模型的第一阶段开放标签剂量递增试验。
  • DOI:
    10.1093/infdis/jiad441
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Azra Blazevic;Rachel L Edwards;Mei Xia;C. Eickhoff;Fahreta Hamzabegovic;Krystal A. Meza;Huan Ning;Jan Tennant;Karla J Mosby;James C Ritchie;Tigisty Girmay;Lilin Lai;Michele McCullough;Allison Beck;Colleen F Kelley;Srilatha Edupuganti;Sarah Kabbani;Wendy Buchanan;M. Makhene;Delia Voronca;Sami R. Cherikh;Johannes B. Goll;N. Rouphael;Mark J. Mulligan;D. Hoft
  • 通讯作者:
    D. Hoft

Colleen F Kelley的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Colleen F Kelley', 18)}}的其他基金

Defining Sex-Specific Systemic and Gut Inflammatory Profiles in People Living with HIV
定义艾滋病毒感染者的性别特异性全身和肠道炎症特征
  • 批准号:
    10619980
  • 财政年份:
    2023
  • 资助金额:
    $ 46.6万
  • 项目类别:
Gender as a biological variable: transcriptomic analysis of rectal mucosal immune cells among transgender people
性别作为生物变量:变性人直肠粘膜免疫细胞的转录组分析
  • 批准号:
    10376886
  • 财政年份:
    2021
  • 资助金额:
    $ 46.6万
  • 项目类别:
Gender as a biological variable: transcriptomic analysis of rectal mucosal immune cells among transgender people
性别作为生物变量:变性人直肠粘膜免疫细胞的转录组分析
  • 批准号:
    10258036
  • 财政年份:
    2021
  • 资助金额:
    $ 46.6万
  • 项目类别:
Parrying the Pitfalls of PrEP: Preventing Premature PrEP Discontinuation and STIs among Young Black MSM
避开 PrEP 的陷阱:防止年轻黑人 MSM 过早停止 PrEP 和性传播感染
  • 批准号:
    9927385
  • 财政年份:
    2020
  • 资助金额:
    $ 46.6万
  • 项目类别:
Parrying the Pitfalls of PrEP: Preventing Premature PrEP Discontinuation and STIs among Young Black MSM
避开 PrEP 的陷阱:防止年轻黑人 MSM 过早停止 PrEP 和性传播感染
  • 批准号:
    10133150
  • 财政年份:
    2020
  • 资助金额:
    $ 46.6万
  • 项目类别:
Parrying the Pitfalls of PrEP: Preventing Premature PrEP Discontinuation and STIs among Young Black MSM
避开 PrEP 的陷阱:防止年轻黑人 MSM 过早停止 PrEP 和性传播感染
  • 批准号:
    10652666
  • 财政年份:
    2020
  • 资助金额:
    $ 46.6万
  • 项目类别:
Parrying the Pitfalls of PrEP: Preventing Premature PrEP Discontinuation and STIs among Young Black MSM
避开 PrEP 的陷阱:防止年轻黑人 MSM 过早停止 PrEP 和性传播感染
  • 批准号:
    10399433
  • 财政年份:
    2020
  • 资助金额:
    $ 46.6万
  • 项目类别:
Understanding the rectal mucosal effects of cross-sex hormone therapy among US and Thai transgender women
了解跨性别激素治疗对美国和泰国变性女性直肠粘膜的影响
  • 批准号:
    10672350
  • 财政年份:
    2019
  • 资助金额:
    $ 46.6万
  • 项目类别:
Understanding the rectal mucosal effects of cross-sex hormone therapy among US and Thai transgender women
了解跨性别激素治疗对美国和泰国变性女性直肠粘膜的影响
  • 批准号:
    10227723
  • 财政年份:
    2019
  • 资助金额:
    $ 46.6万
  • 项目类别:
Understanding the rectal mucosal effects of cross-sex hormone therapy among US and Thai transgender women
了解跨性别激素治疗对美国和泰国变性女性直肠粘膜的影响
  • 批准号:
    10447095
  • 财政年份:
    2019
  • 资助金额:
    $ 46.6万
  • 项目类别:

相似海外基金

Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
  • 批准号:
    MR/Z503605/1
  • 财政年份:
    2024
  • 资助金额:
    $ 46.6万
  • 项目类别:
    Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
  • 批准号:
    2336167
  • 财政年份:
    2024
  • 资助金额:
    $ 46.6万
  • 项目类别:
    Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
  • 批准号:
    2402691
  • 财政年份:
    2024
  • 资助金额:
    $ 46.6万
  • 项目类别:
    Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
  • 批准号:
    24K12150
  • 财政年份:
    2024
  • 资助金额:
    $ 46.6万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
  • 批准号:
    2341428
  • 财政年份:
    2024
  • 资助金额:
    $ 46.6万
  • 项目类别:
    Standard Grant
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
  • 批准号:
    DE240100561
  • 财政年份:
    2024
  • 资助金额:
    $ 46.6万
  • 项目类别:
    Discovery Early Career Researcher Award
Laboratory testing and development of a new adult ankle splint
新型成人踝关节夹板的实验室测试和开发
  • 批准号:
    10065645
  • 财政年份:
    2023
  • 资助金额:
    $ 46.6万
  • 项目类别:
    Collaborative R&D
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
  • 批准号:
    23K09542
  • 财政年份:
    2023
  • 资助金额:
    $ 46.6万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
  • 批准号:
    23K07552
  • 财政年份:
    2023
  • 资助金额:
    $ 46.6万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
  • 批准号:
    23K07559
  • 财政年份:
    2023
  • 资助金额:
    $ 46.6万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了